The trenches are dug in Chicago’s slow-moving budget battle. And as he seeks to gain ground with a government shutdown weeks away, Mayor Brandon Johnson keeps lobbing the same ordnance: harsh words.
Halifax Courier on MSN
'Wendy is known for her unwavering devotion to her role' - Halifax care home manager wins global award
Wendy Johnson, the Home Manager of Rose Lodge Care Home on Gibbet Street, has won the Global Award for the Most Outstanding ...
Todd Feurer is a web producer for CBS Chicago. He has previously written for WBBM Newsradio, WUIS-FM and the New City News Service. Mayor Brandon Johnson on Tuesday declined to veto a $16.6 billion ...
NewcastleWorld on MSN
Every North East nurse removed from the register in the second half of 2025
The Nursing and Midwifery Council can remove professionals from their register for anumber of reasons, including bringing the ...
A jury in Baltimore City Circuit Court awarded $59.84 million to plaintiff Cherie Craft, then added $1 billion in punitive damages against Johnson & Johnson and its subsidiary, Pecos River.
A Los Angeles jury awarded $40 million on Friday to two women who claimed that talcum powder made by Johnson & Johnson caused their ovarian cancer. The giant health care company said it would appeal ...
A Maryland jury ordered Johnson & Johnson to pay more than $1.5B in a lawsuit regarding talc in its baby powder.
Dec 12 (Reuters) - A California jury on Friday awarded $40 million to two women who said Johnson & Johnson’s (JNJ.N), opens new tab baby powder was to blame for their ovarian cancer. The jury in Los ...
A Los Angeles jury awarded $40 million on Friday to two women who claimed that talcum powder made by Johnson & Johnson caused their ovarian cancer. The jury awarded $18 million to Monica Kent and $22 ...
The 37-year-old mom of three said she used the company's baby powder and later developed mesothelioma Charlotte Phillipp is a Weekend Writer-Reporter at PEOPLE. She has been working at PEOPLE since ...
Johnson & Johnson has surged 14% since my last update, surpassing my $188 target, and now trades near $200. Top-line growth is accelerating, but revenue expansion remains below industry rates and is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results